Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

46,050 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Correlations between 14-gene RNA-level assay and clinical and molecular features in resectable non-squamous non-small cell lung cancer: a cross-sectional study.
Huang Z, Zhao M, Li B, Xue J, Wang Y, Wang D, Guo C, Song Y, Li H, Yu X, Liu X, Li R, Cui J, Feng Z, Su L, Fung KL, Rachel HX, Hisakane K, Romero A, Li S, Liang N. Huang Z, et al. Among authors: li s, li h, li b, li r. Transl Lung Cancer Res. 2024 Nov 30;13(11):3202-3213. doi: 10.21037/tlcr-24-913. Epub 2024 Nov 27. Transl Lung Cancer Res. 2024. PMID: 39670022 Free PMC article.
Comprehensive analysis of T cell receptor repertoire in patients with KRAS mutant non-small cell lung cancer.
Wang Y, Peng L, Zhao M, Xiong Y, Xue J, Li B, Huang Z, Liu X, Yang X, Song Y, Bing Z, Guo C, Tian Z, Gao C, Cao L, Cao Z, Li J, Jiang X, Si X, Zhang L, Li X, Zheng Z, Song M, Chen R, Lim WT, Pavan A, Romero A, Liang N, Yang H, Li S. Wang Y, et al. Among authors: li s, li j, li x, li b. Transl Lung Cancer Res. 2022 Sep;11(9):1936-1950. doi: 10.21037/tlcr-22-629. Transl Lung Cancer Res. 2022. PMID: 36248331 Free PMC article.
Efficacy and Safety of Epidermal Growth Factor Receptor (EGFR)-Tyrosine Kinase Inhibitor Combination Therapy as First-Line Treatment for Patients with Advanced EGFR-Mutated, Non-Small Cell Lung Cancer: A Systematic Review and Bayesian Network Meta-Analysis.
Xue J, Li B, Wang Y, Huang Z, Liu X, Guo C, Zheng Z, Liang N, Le X, Li S. Xue J, et al. Among authors: li s, li b. Cancers (Basel). 2022 Oct 6;14(19):4894. doi: 10.3390/cancers14194894. Cancers (Basel). 2022. PMID: 36230817 Free PMC article. Review.
Adjuvant crizotinib treatment selected by patient-derived organoids in a patient with stage IIIA adenocarcinoma with novel LRRTM4-ALK fusion: a case report.
Li B, Jia Z, Huang Z, Xue J, Wang Y, Guo C, Si X, Chen Z, Li J, Chen R, Bie Z, De Giglio A, Christopoulos P, Liang N, Li S. Li B, et al. Among authors: li s, li j. Transl Lung Cancer Res. 2023 Nov 30;12(11):2322-2329. doi: 10.21037/tlcr-23-487. Epub 2023 Oct 30. Transl Lung Cancer Res. 2023. PMID: 38090526 Free PMC article.
Clonal expansion of shared T cell receptors reveals the existence of immune commonality among different lesions of synchronous multiple primary lung cancer.
Wang Y, Huang Z, Li B, Xue J, Guo C, Bing Z, Zheng Z, Song Y, Xu Y, Huang G, Li H, Yu X, Xia Y, Li R, Si X, Zhang L, Li J, Song L, Xiong Y, Gu D, Song M, Zhou Z, Chen R, Feng Z, Bie Z, Li X, Yang H, Li S, Liang N. Wang Y, et al. Among authors: li s, li j, li h, li x, li b, li r. Cancer Immunol Immunother. 2024 Apr 26;73(6):111. doi: 10.1007/s00262-024-03703-8. Cancer Immunol Immunother. 2024. PMID: 38668781 Free PMC article.
46,050 results
You have reached the last available page of results. Please see the User Guide for more information.